Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity.
Journal Information
Full Title: Acta Pharm Sin B
Abbreviation: Acta Pharm Sin B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest The authors have no conflicts of interest to declare."
"This work was supported by the Young Elite Scientists Sponsorship Program by Tianjin (No. 0701320001, China), Major Special Projects (No. 0402080005, China), National Key R&D Program of China (No. 2020YFC1512304, China) and National Natural Science of China (Nos. 82273873, 31971106, and 81372124, China) and the Czech Health Council (AZV NU12J-08–00043, Czech). Moreover, we express our gratitude to Zhi Li (School of Pharmaceutical Science and Technology, Tianjin University, China) for the assistance in the FACS experiments."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025